GB9610093D0 - (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid - Google Patents

(-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid

Info

Publication number
GB9610093D0
GB9610093D0 GBGB9610093.8A GB9610093A GB9610093D0 GB 9610093 D0 GB9610093 D0 GB 9610093D0 GB 9610093 A GB9610093 A GB 9610093A GB 9610093 D0 GB9610093 D0 GB 9610093D0
Authority
GB
United Kingdom
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9610093.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9610093.8A priority Critical patent/GB9610093D0/en
Publication of GB9610093D0 publication Critical patent/GB9610093D0/en
Pending legal-status Critical Current

Links

GBGB9610093.8A 1995-06-01 1996-05-14 (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid Pending GB9610093D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9610093.8A GB9610093D0 (en) 1995-06-01 1996-05-14 (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
GBGB9610093.8A GB9610093D0 (en) 1995-06-01 1996-05-14 (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid

Publications (1)

Publication Number Publication Date
GB9610093D0 true GB9610093D0 (en) 1996-07-17

Family

ID=27267889

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9610093.8A Pending GB9610093D0 (en) 1995-06-01 1996-05-14 (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid

Country Status (1)

Country Link
GB (1) GB9610093D0 (en)

Similar Documents

Publication Publication Date Title
DE69522690T2 (en) alpha-ketogultaric acid dehydrogenase gene
AU1114500A (en) Insertion apparatus for left ventricular access lead
PL326498A1 (en) D-winian(-)cis-6(s)-phenyl-5(r)-[4-(pyrolydin-1-ylethoxy)phenyl]5,6,7,8-tetrahydronaphtalen-2-ol
AU7177296A (en) Crystalline hydrochloride of (R)-(-)-2-N-(4- (1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl)- aminomethyl-chroman
AU8206798A (en) Magazine for rolls of coins
AU4607689A (en) 4-(mono/di-substituted)-1-(sub-alkyl)-piperidines modify protein kinase c activity
ZA96702B (en) 4-(1H-indol-1-yl)-1-piperidinyl derivatives.
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
HU9800511D0 (en) Process for producing 4-{4-[4-(hydroxy-diphenyl)-1-piperidinyl]-1-hydroxy-butyl}-alpha-alpha-dimethyl-phenyl-acetic.acid and phosphorylized derivatives thereof
IL136231A0 (en) Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl} pyrrolidine
HUP9601654A1 (en) Corner or t-joining for frames or scaffolds
GB2304340B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
EP0828493A4 (en) 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
ZA956013B (en) New 1-[4-(aminomethyl)phenyl]-substituted quinolonecarboxylic acids
AU4595100A (en) ((e),3(r))-enantiomer of 4-(3-chloro -4-cyanophenyl) -1-(p- methylsulphonyl -phenylsulphonyl) -2-trifluoromethylbut -trans-3-en-ol
NZ315363A (en) 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof
IL160749A0 (en) Process and intermediate for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl-) phenoxy] ethyl}pyrrolidine
PL313359A1 (en) Method of obtaining 1-{4-[2-(2-methoxy-5-chlorobenzamido)-ethyl]-benzosulphonyl}-3-cyclohexylurea
FR2734818B1 (en) (-) - (3R) -3-METHYL-4- {4- [4- (4-PYRIDYL) PIPERAZINE-1-YL- PHENOXY} -BUTYRIC ACID, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
ZA968020B (en) Novel composition containing an acid labile omeprazole and process for its preparation.
IL116490A0 (en) 4,4-(disubstituted) cyclohexan-1-ol monomers and related compounds
ZA975903B (en) 4-(4-oxocyclohexyl)benzamides
ZA952815B (en) Novel crystal forms of 1-(5-methanesulfonamidoindolyl-2-carbonyl)-4-(3-(1-methylethylamino)-2-pyridinyl) piperazine
NZ329567A (en) 4-(3-cyanophenyl)-2-trifluoromethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline- 3-carboxylic acid preparation